Replies to post #100508 on Amarin Corp Plc (AMRN)

[ziploc_1]

In medical studies, there is always a conflict between what is good for patients and what is good for science. IMO a PE RRR of 30% or more would contraindicate continuing the R-IT study. I believe the chances of this are at least 50:50 or better.